Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
Incyte Corp (NQ: INCY)
74.21 USD  +0.27 (+0.37%)
Streaming Delayed Price  /  Updated: 12:07 PM EDT, Apr 26, 2019  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 536,577
Open 74.41
Bid (Size) 74.19 (2)
Ask (Size) 74.23 (2)
Prev. Close 73.94
Today's Range 73.59 - 74.63
52wk Range 57.00 - 88.83
Shares Outstanding 211,969,163
Dividend Yield N/A
Performance
YTD
+16.76%
+16.76%
1 Month
-14.82%
-14.82%
3 Month
-3.64%
-3.64%
6 Month
+15.43%
+15.43%
1 Year
+17.81%
+17.81%
Top News
More News
Merus Announces Financial Results for the Full Year 2018 and Provides Business Update
Multiple Updates from Biclonics® Clinical Trials Expected in 2019 Read More
from GlobeNewswire News Releases
BriaCell Announces Clinical Trial Collaboration Agreement with Incyte
BriaCell Therapeutics Corp. ("BriaCell" or the "Company") (TSX-V:BCT) (OTCQB:BCTXF), a clinical-stage biotechnology company specializing in targeted immunotherapy for advanced breast cancer, today... Read More
from GlobeNewswire News Releases
More News
Read More
Merus and Incyte Present MCLA-145 Program Preclinical Data at the AACR Annual Meeting 2019
from GlobeNewswire News Releases
Incyte to Report First Quarter Financial Results
from Business Wire News Releases
Comcast Becomes #20 Most Shorted Nasdaq 100 Component, Replacing Incyte
category Stocks
from Market News Video
Innovent Announces 2018 Annual Results
from PR Newswire
Horton Takes Over #308 Spot From Incyte
category Stocks
from Market News Video
Health-care drama has now spread to biopharma stocks
category SPX , Insurance , UNH , and 18 more.
from MarketWatch
UPDATE 2-J&J wins U.S. FDA approval for bladder cancer drug
category companyNews
from Reuters: Company News
UPDATE 1-U.S. FDA approves J&J's bladder cancer drug
category companyNews
from Reuters: Company News
Maxim Integrated Products Becomes #18 Most Shorted Nasdaq 100 Component, Replacing Incyte
category Stocks
from Market News Video
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.